New York’s Medicaid program says Orkambi, a new drug to treat cystic fibrosis, is not worth the price. The case is being closely watched around the country.
from Health https://ift.tt/2twfjFv
June 25, 2018
Rose
Health, Health - The New York Times
No comments
Related Posts:
The Temporary Memory Lapse of Transient Global AmnesiaThose with T.G.A. do not experience any alteration in consciousness or abnormal movements. Only the ability to lay down memories is affected. from Health https://ift.tt/32OKmMR … Read More
Day Care Directors Are Playing Doctor, and Parents SufferMany policies on children with minor ailments are unhelpful. from Health https://ift.tt/2NiKMYc … Read More
Why We Feel Compelled to Say ‘Bless You’ When Someone SneezesAttributing divine blessing to a sneeze may serve various functions when ordinary explanations are lacking. from Health https://ift.tt/30ioCqY … Read More
Purdue Pharma, Maker of OxyContin, Files for BankruptcyThe filing is a centerpiece of an agreement to settle thousands of cases against the company for its role in the opioids crises. But it is expected to be vigorously contested by many states. from Health https://ift.tt/2QaMxc… Read More
When Your Child Gets Sick on a Plane and Needs a DoctorResearch on in-flight emergencies suggests that parents should pack pediatric medicines in their carry-on bags and keep children out of aisle seats. from Health https://ift.tt/2LwjCLe … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment